U.S. doctors reconsider Pfizer's Paxlovid for lower-risk COVID patients

  • 📰 CTVNews
  • ⏱ Reading Time:
  • 41 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 99%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Use of Pfizer Inc's COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a U.S. public health agency warned that symptoms can recur after people complete a course of the drug, and that they should then isolate a second time.

More quarantine time "is not a crowd-pleaser," Dr. Sandra Kemmerly, an infectious disease specialist at Ochsner Health in New Orleans, told Reuters. "For those people who really aren't at risk ... I would recommend that they not take it."

Pfizer, in an email, said it is monitoring the data, but believes the return of detectable virus is uncommon and not uniquely associated with its drug. "We have not seen any resistance emerge to date in patients treated with Paxlovid," a spokesperson said. The CDC also said it is unclear whether cases of rebound symptoms have anything to do with Paxlovid, or are simply part of the natural trajectory of COVID-19. The agency did not flag any specific concerns about health effects.

Some question how much Paxlovid is helping given the high number of people vaccinated or previously infected with COVID-19. The drug was authorized in December after a study in unvaccinated, high-risk COVID-19 patients with conditions like diabetes showed an 88 per cent reduction in hospitalization or death.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

🤯

It's nice to see Pfizer working with the CDC again. The last time they were working together they created covid-19 in their facility in China

Paxlovid was not tested on vaccinated test subjects before FDA inexplicably approved the drug. Yet legacy media in the US and Canada aggressively promoted Paxlovid without scrutiny. In fact, they censored medical professionals for questioning it's effectiveness and validity!

reconsider Pfizer's Paxlovid? guessing here went over the one million deaths safe limit... PFIZER...IS 1

I believe it’s a money maker for Pfizer find a cure for ALS , Ms etc

Lower risk than the super safe and super effective vaxx? How is Teresa Tam not in prison yet? Is she even still in the country? Was she ever?

How much does Pfizer/Moderna pay Ctv?

But not in BC because it’s mild, long covid is “anxiety” and kindness is paramount to paxlovid.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 1. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Ontario reports lowest COVID-19 ICU occupancy in 6 monthsOn Saturday provincial health officials reported the lowest number of COVID-19 patients in intensive care in six months. Oh nooo. What will the Karens bitch about now? There were more deaths in May than April That's great news!
Source: CP24 - 🏆 30. / 67 Read more »